Adipotide and Tirzepatide Interaction

Monitor
Researched 90% confidence

Adipotide and Tirzepatide have an interaction requiring monitoring for interaction with 90% confidence. Overlapping weight-loss effects; monitor kidney function, volume status, electrolytes. Both compounds affect the gi tract, so monitoring these systems is recommended.

Compound Profiles

Adipotide

Prohibitin-Targeting Peptidomimetic | Experimental Anti-Obesity

CKGGRAKDC ligand homes to prohibitin/annexin A2 on white-fat endothelium; linked D-(KLAKLAK)2 disrupts mitochondrial membranes post-internalization, triggering localized endothelial apoptosis and adipocyte loss..

Half-life: Not established Typical dose: 0.43 mg/kg weight loss
teratogenic
View full profile

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes

Dual agonist targeting both GIP and GLP-1 receptors, producing glucose-dependent insulin stimulation, delayed gastric emptying, glucagon suppression, and central satiety signaling via hypothalamic pathways..

Half-life: ~5 days (120 hours) Typical dose: 2.5mg starting, titrate up to 5-15mg weekly weight loss, metabolic
glp1 receptor teratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Adipotide, Tirzepatide). Monitor accordingly.

Frequently Asked Questions

Can I take Adipotide with Tirzepatide?

Yes, but with caution. Overlapping weight-loss effects; monitor kidney function, volume status, electrolytes. Regular monitoring is advised.

Is Adipotide and Tirzepatide safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Adipotide and Tirzepatide?

Overlapping weight-loss effects; monitor kidney function, volume status, electrolytes. This assessment has 90% confidence and is based on documented research data.

How should I time Adipotide and Tirzepatide?

Adipotide has a half-life of Not established and Tirzepatide has a half-life of ~5 days (120 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Adipotide vs Tirzepatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.